What Researchers Did
Researchers retrospectively reviewed the medical records of six patients who received once-daily hyperbaric oxygen therapy (HBOT) for radiation-induced vaginal soft tissue necrosis.
What They Found
Out of six patients treated with HBOT, four (67%) showed documented improvement in radionecrosis. Four of five patients (80%) with pelvic pain found relief, with two no longer needing opioid pain medication. Additionally, both patients with vaginal bleeding saw improvement, with one resolving completely and the other significantly decreasing, leading to an overall improvement in at least one outcome for five out of six (83%) patients.
What This Means for Canadian Patients
This research suggests that hyperbaric oxygen therapy could be a beneficial treatment option for Canadian women experiencing vaginal soft tissue necrosis due to pelvic radiation therapy. It offers potential relief from debilitating symptoms like pelvic pain and vaginal bleeding, which could significantly improve their quality of life. This is relevant as delayed radiation injury is a Health Canada-recognised indication for HBOT.
Canadian Relevance
While this study was not conducted in Canada, it covers delayed radiation injury, which is a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
A significant limitation of this study is its very small sample size, involving only six patients treated with HBOT.